Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
SBI Holdings, Inc. (8473.T)
Tokyo, JP
SBI Holdings, Inc. is a Japanese conglomerate primarily engaged in online financial services and strategic investments, both domestically and internationally. Its operations are structured around three key pillars: Financial Services, Asset Management, and the Biotechnology, Healthcare, and Medical Informatics sectors. The company provides a comprehensive suite of financial products, including online brokerage, investment banking, and internet banking facilities. It offers various insurance solutions such as automobile, health (cancer), property (fire, earthquake), and life coverage, alongside short-term insurance. Further financial offerings encompass foreign exchange (FX) margin trading, online securities, and services related to digital asset exchange and transactions. SBI also manages defined-contribution pension schemes, provides leasing and lending services, and operates a proprietary trading system. Its involvement extends to e-commerce settlement processing, remittance services, and essential back-office support. Beyond traditional banking, SBI is active in private equity and venture capital fund management, offers mergers and acquisitions (M&A) advisory, and runs savings and commercial banking operations. It provides investment advisory and management services, alongside rating information services. The firm also deals with real estate-secured loans and offers rent guarantees for residential properties. In the biotechnology and healthcare domain, SBI conducts research, manufactures, and distributes pharmaceutical products, health supplements, and cosmetics. It develops, produces, sells, and maintains integrated medical information systems. Furthermore, it's involved in the research and development of advanced antibody and nucleic acid drugs targeting cancer and immunological conditions. The company's diverse portfolio includes operating a fund-raising platform, serving as a crypto-asset broker, and developing, manufacturing, and selling crypto-asset mining systems. It also develops and manages cybersecurity systems, provides blockchain platforms, invests in real estate, and engages in used car exports. Additionally, SBI offers healthcare services, participates in revitalization projects, mines digital assets, and is involved in e-sports and renewable energy initiatives. Established in 1999, the company was initially known as Softbank Investment Corporation before adopting its current name, SBI Holdings, Inc., in July 2005. Its headquarters are located in Tokyo, Japan.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.03% | -2.83% | -1.10% | -15.11% | -12.28% | -11.68% | +56.84% | +134.00% | +114.61% | +389.35% | -26.66% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 3 | 0 |
| Buy | 3 | 0 |
| Hold | 1 | -1 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Asset Management: +13.3%+13.8% ★ Q1'26: +13.2% (vs Q1'25)
-
EPS growth Asset Management: +19.3%+79.5% ★ Q1'26: +20.4% (vs Q1'25)
-
FCF margin Asset Management: +27.4%+120.8% ★ Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Asset Management: +53.6%+38.5% Q1'26: +17.1% (vs Q1'25)
-
ROIC Asset Management: +5.7%+10.8% ★ Q1'26: +16.0% (vs Q1'25)
-
Share dilution Asset Management: +0.0%+4.0% Q1'26: +5.5% (vs Q1'25)
-
Debt / EBITDA Asset Management: 0.00×13.30× ★ Q1'26: 17.24× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 5 Rev. Ana. 7 EPS Ana. |
Mar 2027 4 Rev. Ana. 5 EPS Ana. |
Mar 2028 5 Rev. Ana. 7 EPS Ana. |
Mar 2029 3 Rev. Ana. 3 EPS Ana. |
Mar 2030 1 Rev. Ana. 1 EPS Ana. |
Mar 2031 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
245.05B
est: 225.89B (+8.5%)
|
261.74B
est: 247.50B (+5.8%)
|
263.47B
est: 264.10B (-0.2%)
|
299.32B
est: 300.00B (-0.2%)
|
319.92B
est: 338.59B (-5.5%)
|
344.15B
est: 363.90B (-5.4%)
|
521.94B
est: 455.55B (+14.6%)
|
650.48B
est: 738.01B (-11.9%)
|
911.97B
est: 802.07B (+13.7%)
|
1.19T
est: 1.24T (-4.0%)
|
1.35T
est: 1.30T (+4.2%)
|
1.71T
1.34T – 2.45T
+31.4% YoY
|
1.47T
1.34T – 1.54T
-14.0% YoY
|
1.55T
1.14T – 2.65T
+5.3% YoY
|
1.59T
1.30T – 2.26T
+2.9% YoY
|
1.70T
1.39T – 2.42T
+7.1% YoY
|
1.95T
1.60T – 2.77T
+14.6% YoY
|
| EBITDA |
101.78B
est: 53.88B (+88.9%)
|
85.19B
est: 59.04B (+44.3%)
|
71.55B
est: 63.00B (+13.6%)
|
103.73B
est: 71.56B (+44.9%)
|
118.94B
est: 80.77B (+47.3%)
|
111.69B
est: 86.80B (+28.7%)
|
196.81B
est: 108.66B (+81.1%)
|
487.00B
est: 176.04B (+176.6%)
|
278.63B
est: 191.32B (+45.6%)
|
404.96B
est: 528.26B (-23.3%)
|
581.39B
est: 553.99B (+4.9%)
|
728.19B
570.28B – 1.04T
+31.4% YoY
|
625.97B
573.32B – 655.15B
-14.0% YoY
|
658.99B
488.24B – 1.13T
+5.3% YoY
|
678.35B
554.63B – 963.50B
+2.9% YoY
|
726.59B
594.07B – 1.03T
+7.1% YoY
|
832.85B
680.96B – 1.18T
+14.6% YoY
|
| EBIT |
90.26B
est: 43.33B (+108.3%)
|
74.09B
est: 47.47B (+56.1%)
|
61.16B
est: 50.66B (+20.7%)
|
92.88B
est: 57.54B (+61.4%)
|
109.11B
est: 64.95B (+68.0%)
|
96.15B
est: 69.80B (+37.7%)
|
172.96B
est: 87.38B (+97.9%)
|
454.88B
est: 141.56B (+221.3%)
|
224.60B
est: 153.85B (+46.0%)
|
351.22B
est: 470.40B (-25.3%)
|
521.73B
est: 493.31B (+5.8%)
|
648.43B
507.82B – 929.79B
+31.4% YoY
|
557.41B
510.52B – 583.40B
-14.0% YoY
|
586.81B
434.77B – 1.00T
+5.3% YoY
|
604.05B
493.89B – 857.97B
+2.9% YoY
|
647.01B
529.01B – 918.98B
+7.1% YoY
|
741.63B
606.38B – 1.05T
+14.6% YoY
|
| Net Income |
45.72B
est: 131.31B (-65.2%)
|
34.12B
est: 40.43B (-15.6%)
|
32.46B
est: 40.80B (-20.4%)
|
46.68B
est: 73.90B (-36.8%)
|
52.55B
est: 73.26B (-28.3%)
|
37.49B
est: 61.63B (-39.2%)
|
81.10B
est: 101.16B (-19.8%)
|
366.85B
est: 506.08B (-27.5%)
|
35.45B
est: 61.83B (-42.7%)
|
87.24B
est: 235.55B (-63.0%)
|
162.12B
est: 162.65B (-0.3%)
|
427.58B
381.92B – 475.17B
+162.9% YoY
|
308.53B
267.80B – 349.26B
-27.8% YoY
|
227.83B
155.24B – 329.22B
-26.2% YoY
|
203.17B
159.29B – 249.13B
-10.8% YoY
|
278.09B
212.16B – 430.06B
+36.9% YoY
|
305.41B
233.00B – 472.31B
+9.8% YoY
|
| SGA |
—
est: 73.35B (-100.0%)
|
—
est: 80.37B (-100.0%)
|
—
est: 85.76B (-100.0%)
|
—
est: 97.41B (-100.0%)
|
—
est: 109.94B (-100.0%)
|
—
est: 118.16B (-100.0%)
|
—
est: 147.92B (-100.0%)
|
—
est: 239.64B (-100.0%)
|
—
est: 260.44B (-100.0%)
|
—
|
—
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EPS |
105.59
est: 206.62 (-48.9%)
|
80.42
est: 63.62 (+26.4%)
|
79.69
est: 64.20 (+24.1%)
|
110.27
est: 116.29 (-5.2%)
|
115.72
est: 115.28 (+0.4%)
|
81.59
est: 96.97 (-15.9%)
|
169.89
est: 159.19 (+6.7%)
|
749.28
est: 796.36 (-5.9%)
|
66.94
est: 86.88 (-23.0%)
|
158.21
est: 297.23 (-46.8%)
|
268.04
est: 205.25 (+30.6%)
|
623.37
556.49 – 692.36
+203.7% YoY
|
465.32
390.20 – 508.89
-25.4% YoY
|
346.18
226.19 – 479.69
-25.6% YoY
|
314.20
232.10 – 363.00
-9.2% YoY
|
405.20
309.13 – 626.63
+29.0% YoY
|
445.00
339.49 – 688.18
+9.8% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | B+ | 3/5 | 1/5 | 5/5 | 4/5 | 1/5 | 4/5 | 3/5 |
| 2026-05-11 | B+ | 3/5 | 1/5 | 5/5 | 4/5 | 1/5 | 4/5 | 3/5 |
| 2026-05-08 | B+ | 3/5 | 1/5 | 5/5 | 4/5 | 1/5 | 4/5 | 3/5 |
| 2026-05-07 | B+ | 3/5 | 1/5 | 5/5 | 4/5 | 1/5 | 4/5 | 3/5 |
| 2026-05-01 | B | 3/5 | 1/5 | 5/5 | 4/5 | 1/5 | 4/5 | 2/5 |
| 2026-04-30 | B | 3/5 | 1/5 | 5/5 | 4/5 | 1/5 | 4/5 | 2/5 |
| 2026-04-28 | B | 3/5 | 1/5 | 5/5 | 4/5 | 1/5 | 4/5 | 2/5 |
| 2026-04-27 | B | 3/5 | 1/5 | 5/5 | 4/5 | 1/5 | 4/5 | 2/5 |
| 2026-04-24 | B | 3/5 | 1/5 | 5/5 | 4/5 | 1/5 | 4/5 | 2/5 |
| 2026-04-23 | B | 3/5 | 1/5 | 5/5 | 4/5 | 1/5 | 4/5 | 2/5 |
| 2026-04-22 | B | 3/5 | 1/5 | 5/5 | 4/5 | 1/5 | 4/5 | 2/5 |
| 2026-04-21 | B | 3/5 | 1/5 | 5/5 | 4/5 | 1/5 | 4/5 | 2/5 |
| 2026-04-20 | B | 3/5 | 1/5 | 5/5 | 4/5 | 1/5 | 4/5 | 2/5 |
| 2026-04-17 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 3/5 |
| 2026-04-16 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 3/5 |
| 2026-04-15 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 3/5 |
| 2026-04-14 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 3/5 |
| 2026-04-13 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 3/5 |
| 2026-04-10 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Yoshitaka Kitao | Chairman of the Board, President & Chief Executive Officer | 329M | male |
| Masato Takamura | Senior EVice President, Chief Operating Officer, Senior Head of Financial Services Business & Representative Director | 207M | male |
| Tomoya Asakura | Senior Executive Vice President & Representative Director | 129M | male |
| Hideyuki Katsuchi | Executive Officer of Accounting & Finance | — | male |
| Yasuo Nishikawa | Executive Officer, Chief Financial Officer & Director | — | male |
| Satoe Kusakabe | MD & Director | — | female |
| Masashi Okuyama | Executive Officer, GM of the Legal & Compliance and Director | — | male |
| Motoaki Shiino | GM of Corporate Communication Department & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 8473.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
